IRIS Institutional Research Information System - AIR Archivio Istituzionale della Ricerca

Asthma remission one, none and one-hundred thousand: the relevance of the patient's view / M. Bonini, S. Barbaglia, G. Camiciottoli, S. Del Giacco, F. Di Marco, A. Matucci, C. Micheletto, A. Papi, P. Pasqualetti, G. Pelaia, F.L.M. Ricciardolo, P. Rogliani, G. Senna, M. Triggiani, C. Vancheri, G.W. Canonica. - In: THE JOURNAL OF ASTHMA. - ISSN 0277-0903. - (2024), pp. 1-10. [10.1080/02770903.2024.2366523]

Asthma remission one, none and one-hundred thousand: the relevance of the patient's view

F. Di Marco;
2024
Objective: Achieving remission in severe asthma holds paramount importance in elevating patient quality of life and reducing both individual and societal burdens associated with this chronic condition. This study centers on identifying pivotal patient-relevant endpoints through standardized, reproducible methods, while also developing a patient-centric definition of remission, essential for effective disease management. Methods: A discrete choice experiment (DCE) was conducted to assess patients' perceptions on the four primary criteria for defining severe asthma remission, as outlined by the SANI survey. Additionally, it investigated the correlation between these perceptions and improvements in the doctor-patient therapeutic alliance during treatment decision-making. Results: 249 patients (70% aged between 31-60, 59% women and 82% without other pathologies requiring corticosteroids) prioritize the use of oral corticosteroids (OCS, 48%) and the Asthma Control Test (ACT, 27%) in defining their condition, ranking these above lung function and exacerbations. This preference for OCS stems from its direct role in treatment, tangible tracking, immediate symptom relief, and being a concrete measure of disease severity compared to the less predictable and quantifiable exacerbations. Conclusions: This study explores severe asthma remission from patients' perspectives using clinician-evaluated parameters. The DCE revealed that most patients highly value OCS and the ACT, prefer moderate improvement, and avoid cortisone cycles. No definitive preference was found for lung function status. Integrating patient-reported information with professional insights is crucial for effective management and future research. Personalized treatment plans focusing on patient preferences, adherence, and alternative therapies aim to achieve remission and enhance quality of life.
Asthma; discrete-choice experiment; patient; personalized medicine; remission
Settore MED/10 - Malattie dell'Apparato Respiratorio
2024
25-giu-2024
THE JOURNAL OF ASTHMA
Article (author)
01 - Articolo su periodico
File in questo prodotto:
File Dimensione Formato  
Asthma remission one none and one-hundred thousand the relevance of the patient s view.pdf

accesso aperto

Descrizione: Research Article
Tipologia: Publisher's version/PDF
Dimensione 2.28 MB
Formato Adobe PDF
Visualizza/Apri
2.28 MB Adobe PDF Visualizza/Apri
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/1084628
Citazioni
  • ???jsp.display-item.citation.pmc??? 0
  • Scopus 0
  • ???jsp.display-item.citation.isi??? 0
social impact